Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 0.05%.

  • Eton Pharmaceuticals' Return on Capital Employed rose 3200.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 3200.0%. This contributed to the annual value of 0.08% for FY2024, which is 200.0% up from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Return on Capital Employed stood at 0.05%, which was up 3200.0% from 0.01% recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.09% for Q3 2023, and its period low was 0.57% during Q2 2022.
  • For the 5-year period, Eton Pharmaceuticals' Return on Capital Employed averaged around 0.25%, with its median value being 0.34% (2023).
  • In the last 5 years, Eton Pharmaceuticals' Return on Capital Employed skyrocketed by 18400bps in 2021 and then tumbled by -4600bps in 2024.
  • Over the past 5 years, Eton Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.07% in 2021, then tumbled by -639bps to 0.49% in 2022, then soared by 84bps to 0.08% in 2023, then grew by 7bps to 0.07% in 2024, then skyrocketed by 37bps to 0.05% in 2025.
  • Its Return on Capital Employed was 0.05% in Q3 2025, compared to 0.01% in Q2 2025 and 0.04% in Q1 2025.